Drug Type AAV based gene therapy |
Synonyms Cone Rod Dystrophy (Beacon Therapeutics) |
Target |
Mechanism CDHR1 inhibitors(cadherin related family member 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Beacon Therapeutics Ltd.Startup |
Active Organization Beacon Therapeutics Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cone-Rod Dystrophies | Preclinical | GB | Beacon Therapeutics Ltd.Startup | 06 Jun 2024 |